Articles related to ANTIPSYCHOTICS

The recent FDA approval of brexpiprazole for Alzheimer’s dementia patients has ignited concerns among healthcare professionals. Physicians are urged to carefully consider the drug’s minimal efficacy and increased mortality risk in their treatment decisions.

Explore the latest research on non-dopaminergic mechanisms for schizophrenia treatment, revealing innovative approaches that may lead to more effective and well-tolerated therapies.

The latest systematic review on olanzapine for schizophrenia treatment has defined a therapeutic reference range of 20-40 ng/mL, offering insight into optimal efficacy and tolerable levels. Explore the full study to understand how these findings can inform clinical practice and patient care.

This groundbreaking study from Northwestern Medicine unveils a surprising interaction of antipsychotic drugs with neurons, prompting a revision of our understanding of psychosis treatment and opening new pathways for more effective, safer drugs.

Study Reveals Different Effects of Antipsychotics on Weight Gain: Key Findings for Physicians A new study analyzed the impact of different antipsychotic medications on weight gain, emphasizing the importance of considering dose and specific drugs for individual patients. The study provides valuable insights for physicians to make informed decisions regarding antipsychotic use. Key Points: “Weight gain from medication is one of the most problematic adverse effects facing patients with serious mental illness… It can be a real barrier in getting people to take their meds.” Michel Sabé, MD, corresponding author

Understanding the Effects of Drugs with Depressive Symptom Side Effects on Patients with MDD Learn more about the complex interaction between the usage of specific drugs and the severity of depressive symptoms in people with major depressive disorder (MDD).